3 01, 2024

Moderna Climbs 13% After Analyst Upgrades to a Buy: Why MRNA is Still Rated a Hold at VectorVest

By |2024-01-03T17:25:19+00:00January 3rd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Shares of Moderna (MRNA) climbed 13% in yesterday’s trading session after being upgraded to a buy at Oppenheimer. The stock fell a bit in Wednesday’s trading session, but has since settled at around even on the day. Hartaj Singh and a team of analysts see dramatic upside potential over the next few years for [...]

13 09, 2023

Is Rocket Pharmaceuticals a Buy as the Stock Soars on FDA Trial Update? 3 Things to Consider

By |2023-12-07T19:52:55+00:00September 13th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Gene therapy developer Rocket Pharmaceuticals (RCKT) investors woke up in delight as shares skyrocketed in Wednesday morning’s pre-market trading session. When the bell sounded, the stock continued its trajectory and it currently sits 38% higher than it last closed at. This comes after the company announced that it has aligned with the Food and [...]

18 07, 2023

AudioCodes is Down 55% This Year, and it May Get Worse: Time to Sell?

By |2023-12-07T20:46:09+00:00July 18th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Recursion Pharmaceuticals (RXRX) just got an endorsement from one of Wall Street’s hottest stocks at the moment, and as such, has earned the attention of analysts, retail investors, and professionals alike. After securing a $50 million investment from Nvidia (NVDA), the RXRX shot up more than 76%. The two companies are more alike than [...]

1 05, 2023

Will Protalix BioTherapeutics Keep Powering Higher After its 178% Run Up Since November 2022?

By |2023-12-07T20:56:34+00:00May 1st, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Protalix BioTherapeutics, Inc. (PLX: NYSE AMEX and Tel Aviv Stock Exchange) is headquartered in Carmiel, Israel with an office in Hackensack, NJ, with a total of 197 employees. Protalix Ltd. was incorporated in 1993. It became a U.S public company on December 31, 2006. PLX is a biopharmaceutical company that develops, produces and commercializes [...]

28 03, 2023

Moderna Deal Sends Generation Bio Shares 34% Higher…Should You Take a Chance on This Stock?

By |2023-12-07T20:58:18+00:00March 28th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

Last week Moderna (MRNA) announced a licensing deal with Generation Bio that they hope will allow them to overcome the losses they’re facing now that the COVID-19 pandemic has come and gone. And as a result of this deal, Generation Bio (GBIO) gained 34% in the past week of trading. The partnership will have [...]

Go to Top